Brief: IPSEN: Arbitration Tribunal Upholds Ipsen's Termination Of Research And Development Agreement With Galderma
21/01/2026 16:50
Jan 21 (Reuters) - Ipsen SA IPN.PA: IPSEN: ARBITRATION TRIBUNAL UPHOLDS IPSEN’S TERMINATION OF RESEARCH AND DEVELOPMENT AGREEMENT WITH GALDERMA IPSEN SAYS ICC DISMISSES GALDERMA'S CLAIM IN ARBITRATION IPSEN CEO: WE CONTINUE TO ASSESS ALL OPTIONS TO MAXIMIZE VALUE OF IPN10200 Source text: nGNX76KcgH Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients